Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Kane Biotech Inc (KNE.VN)

Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 7,460
  • Shares Outstanding, K 165,772
  • Annual Sales, $ 2,081 K
  • Annual Income, $ 6,098 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta -0.18
  • Price/Sales 2.55
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.02
  • Most Recent Earnings $-0.01 on 05/29/25
  • Next Earnings Date 09/04/25
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING TSX Biotechnology

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.040 +12.50%
on 07/15/25
0.060 -25.00%
on 06/30/25
-0.010 (-18.18%)
since 06/16/25
3-Month
0.040 +12.50%
on 07/15/25
0.095 -52.63%
on 04/25/25
-0.050 (-52.63%)
since 04/16/25
52-Week
0.040 +12.50%
on 07/15/25
0.160 -71.88%
on 08/21/24
-0.095 (-67.86%)
since 07/16/24

Most Recent Stories

More News
Kane Biotech to Present at Advanced Wound Care Summit USA

WINNIPEG, Manitoba, July 14, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE) (“Kane Biotech” or “Kane”) announces today that Kane Biotech’s Interim Chief Executive Officer, Dr.

KNE.VN : 0.045 (unch)
KNBIF : 0.0332 (-5.14%)
Kane Biotech Provides Further Corporate Update

KNE.VN : 0.045 (unch)
KNBIF : 0.0332 (-5.14%)
Kane Biotech Announces First Quarter 2025 Financial Results

KNE.VN : 0.045 (unch)
KNBIF : 0.0332 (-5.14%)
Kane Biotech Announces Fourth Quarter and Full Year 2024 Financial Results, Narrows Strategic Focus and Makes Leadership Change

KNE.VN : 0.045 (unch)
KNBIF : 0.0332 (-5.14%)
Kane Biotech Secures IRB Approval to Launch Innovative DispersinB® Acne Trial

KNE.VN : 0.045 (unch)
KNBIF : 0.0332 (-5.14%)
Kane Biotech Announces Canadian Distribution Agreement With Best Buy Medical for revyve™ Antimicrobial Wound Gel

KNE.VN : 0.045 (unch)
KNBIF : 0.0332 (-5.14%)
Kane to Host Investor Webinar – What Kane has in Store for 2025 Including the Acquisition of FB Dermatology

KNE.VN : 0.045 (unch)
KNBIF : 0.0332 (-5.14%)
Kane Biotech Announces First Closing of Private Placement Offering and Extension of Private Placement Offering

KNE.VN : 0.045 (unch)
KNBIF : 0.0332 (-5.14%)
Kane Biotech Announces $3,000,000 Private Placement Offering

KNE.VN : 0.045 (unch)
KNBIF : 0.0332 (-5.14%)
Kane Biotech Announces Third Quarter 2024 Financial Results

KNE.VN : 0.045 (unch)
KNBIF : 0.0332 (-5.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise...

See More

Key Turning Points

3rd Resistance Point 0.045
2nd Resistance Point 0.045
1st Resistance Point 0.045
Last Price 0.045
1st Support Level 0.045
2nd Support Level 0.045
3rd Support Level 0.045

See More

52-Week High 0.160
Fibonacci 61.8% 0.114
Fibonacci 50% 0.100
Fibonacci 38.2% 0.086
Last Price 0.045
52-Week Low 0.040

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar